<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0" xmlns:cc="http://cyber.law.harvard.edu/rss/creativeCommonsRssModule.html">
    <channel>
        <title><![CDATA[Stories by Catharine Dockery on Medium]]></title>
        <description><![CDATA[Stories by Catharine Dockery on Medium]]></description>
        <link>https://medium.com/@catharine_75466?source=rss-c6e6662c8b6c------2</link>
        <image>
            <url>https://cdn-images-1.medium.com/fit/c/150/150/1*JxgvhwxDwaqjhp8s1eSmTA.png</url>
            <title>Stories by Catharine Dockery on Medium</title>
            <link>https://medium.com/@catharine_75466?source=rss-c6e6662c8b6c------2</link>
        </image>
        <generator>Medium</generator>
        <lastBuildDate>Sat, 21 Nov 2026 17:21:40 GMT</lastBuildDate>
        <atom:link href="https://medium.com/@catharine_75466/feed" rel="self" type="application/rss+xml"/>
        <webMaster><![CDATA[yourfriends@medium.com]]></webMaster>
        <atom:link href="http://medium.superfeedr.com/" rel="hub"/>
        <item>
            <title><![CDATA[Nothing Butt Litter]]></title>
            <link>https://medium.com/@catharine_75466/nothing-butt-litter-c9492d235684?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/c9492d235684</guid>
            <category><![CDATA[vice-ventures]]></category>
            <category><![CDATA[garbage]]></category>
            <category><![CDATA[cigarettes]]></category>
            <category><![CDATA[environment]]></category>
            <category><![CDATA[harm-reduction]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Tue, 11 Jan 2022 18:48:07 GMT</pubDate>
            <atom:updated>2022-01-11T18:48:07.265Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*LSxXdxMB3s6iX0xAIjC52g.jpeg" /></figure><p>Picture this: it’s a beautiful day with the sun out and you’re driving in your car with the windows down. You’re smoking a cigarette and tapping the ashes out the open window. You’ve just about reached the end: Where do you put the butt of your cigarette when you’re done?</p><p>A commonly found object on the ground, cigarette butts appear to blend into their environment. Small enough to seem insignificant, yet strangely colored enough to differentiate from naturally occurring objects, the butts have become a normal part of the landscape. Due to their tiny size, the effect of these individual butts is always overlooked, disregarded, and not deemed important enough to do something about.</p><p>Cigarette butts account for 20% of all litter in ocean clean ups and have been named the most abundant form of litter in the world, with about 4.5 trillion individual butts polluting the environment <a href="https://www.sciencedirect.com/science/article/abs/pii/S0013935119300787">yearly</a>. The 1.3 billion smokers in the world, or 16% of the global population, smoke 6 trillion cigarettes a year. This equates to an astounding 75% of cigarettes end up as litter.</p><p>There are a multitude of reasons why cigarettes are the most commonly found waste: laziness to find a trash can for a piece of waste smaller than a pinky finger, the (false) belief that it’s made up of paper and therefore is semi-compostable, or even just being on the move and unable to find an appropriate place to dispose of the butt. While people may speculate on the reasons, none of them lead to a solution that would cease the endless cycle of waste and pollution.</p><p>For their small size, cigarette butts cause a large amount of harm. Cigarette butts are composed of four materials: a filter, burned and unburned tobacco, ashes, and paper. The filter is made of a synthetic polymer, cellulose acetate. Due to this molecule, <strong>cigarette butts take 10 years to </strong><a href="https://www.conserve-energy-future.com/30-practical-ways-to-cut-fuel-and-help-the-environment.php"><strong>decompose</strong></a>. The other chemicals (including, but not limited to, arsenic and formaldehyde) that leach from a cigarette butt could be toxic enough to kill 50% of the saltwater and freshwater fish that are exposed to it for <a href="https://www.vapingpost.com/2022/01/06/how-cigarette-butts-affect-the-environment/">96 hours</a>. Researchers estimate that over one million animals die each year due to <a href="https://www.texasdisposal.com/blog/the-real-cost-of-littering/">litter</a>. On a more pertinent note, litter also facilitates the spread of disease. The carelessly abandoned garbage is a breeding ground for bacteria and diseases and can spread viruses and parasites to both humans and animals through indirect and direct contact.</p><p>It is a well documented fact that cigarettes are harmful to the smoker; however, more light is now being shed on their impact on the environment. With the number of global smokers decreasing, the onus is now on alternative tobacco products, such as vapes, lozenges, and pouches to address their environmental impact. Most vapes have cartridges that are single-use and not able to be recycled. On the other hand, dip and pouches do not contribute to air pollution and it is easier for them to be discarded responsibly through catch-lid compartments in the containers. Lucy, an oral nicotine company, has a mission of reducing tobacco-related harm to zero, which includes the effects on the environment. Vice Ventures remains committed to our thesis of harm reduction, which comes in many shapes and sizes, and we are proud to back Lucy in this mission.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c9492d235684" width="1" height="1" alt="">]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[NYS Legalization: An End to the War on Drugs is Just the Beginning]]></title>
            <link>https://medium.com/vice-ventures/an-end-to-war-on-drugs-is-just-the-beginning-3c410601a4a3?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/3c410601a4a3</guid>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Mon, 05 Apr 2021 21:12:29 GMT</pubDate>
            <atom:updated>2021-04-05T21:28:45.053Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*3I9srG20TtAnZAmCcLId9Q.png" /></figure><p>One of the biggest triumphs of New York’s long-awaited legalization of recreational cannabis has been the focus on social justice, but as is often the case with this sort of progress, the work is by no means complete. NY has already gained significant attention for the social impact focus within the legalization push, largely driven by the incredible Drug Policy Alliance, an organization that’s been a leader in reframing drug conversations in the US towards community impact.</p><p>The evidence is depressingly clear that the War on Drugs has really been the facade for a multi-decade attack on minority communities. Cannabis has perhaps been the dark centerpiece of that policy as a commonly-consumed substance that has remained a Schedule I drug since 1970 (no accepted medical use and high potential for abuse) despite clear medical and scientific evidence to discredit that classification.</p><p>As someone who’s never been stopped by the police because an officer claimed to smell cannabis, I’ve experienced real privilege. While impaired driving is absolutely a major concern (legalization has not been shown to increase DUIs, and may reduce drunk driving and other crime), there’s no evidence to suggest that the disparity in cannabis policy enforcement is driven by safety or any other valid considerations. Make no mistake of it, in locations where cannabis remains illegal in any format (it’s still federally illegal across the US), cannabis is being used as the basis for overly aggressive policing, in our opinion frequently violating constitutional rights against unreasonable searches. These patterns, if anything, have remained static through decriminalization — roughly 95% of cannabis-related arrests in NYC were people of color in 2020.</p><p>This terrible enforcement failure of already-biased policies is finally coming to an end in NY, and not a moment too soon. NYPD guidance on cannabis has already been issued, including that “Effective immediately, the smell of marijuana alone no longer establishes probable cause of a crime to search a vehicle.” As with other broken-windows policing policies, some will mourn the loss of a policy that was so effective in enabling aggressive searches — though of those complainers have had to suffer the effects of over enforcement or had their neighborhoods labeled as high-crime because the police unevenly enforced drug policy there.</p><p>In addition to the progress on policing, the new act also promises to fund policies for recovery in the communities that carried the burden of overenforcement. 40% of tax revenue — estimated to total $350M annually — will be reinvested in the communities that need it most. This reinvestment is truly revolutionary, and being done on a scale far larger than we saw in prior state legalizations. Activists like the Drug Policy Alliance should be incredibly proud of the success they’ve been able to achieve here, and we hope that NY’s focus on community reinvestment can be part of the state legalization model going forward.</p><p>The next steps in NY state legalization will be incredibly important as well. One area where we’re especially interested in future policy development is licensing policy from the newly formed Office of Cannabis Management. In other state legalizations so far, we’ve unfortunately seen smaller (and unfortunately, local and minority) operators suffer from heavy capital requirements and significant operational and compliance costs. When NY legalized medical cannabis, this was very much the case: application fees were $10k (nonrefundable), license fees were $200k (refunded only if the application is rejected) and applicants needed a property, lease option, or to post $2M bond. Beyond that capital burden, even well-capitalized and highly organized groups failed to win approval in the heavily limited and very competitive process — even Tilray, who submitted a <a href="https://www.health.ny.gov/regulations/medical_marijuana/application/docs/tilray.pdf">741 page application</a> in the roughly 6-week window and still wasn’t chosen. If that’s the process again, what hope does a small local business have?</p><p>As the Office for Cannabis Management begins to get moving, we hope to work with them to ensure the process doesn’t leave behind the very communities that were hurt by the War on Drugs. As we move cannabis businesses into legal markets, the focus on using this economic force for community reinvestment needs to also grow beyond tax revenue distribution and into business ownership and high-quality jobs.</p><p>Lowering the bar for participation in the industry while still maintaining high operating standards is a key way that the regulators can ensure the upside of the cannabis industry is fairly shared. Clearly, the astronomical application fees need to be reconsidered and in the context of similar licenses for bars, liquor stores, bodegas, and other sellers of nicotine products, etc. As we continue to adjust laws for cannabis consumption towards those for nicotine or alcohol, it’s remarkably inconsistent to have such high regulatory startup costs, and likely to discourage currently illegal operators to move into regulated markets.</p><p>Beyond that, if cannabis banking laws continue to stall out in Congress, the state should look at ways to facilitate banking and borrowing for cannabis small businesses, as the current system makes it near-impossible for small operators to access capital as other businesses do. Cannabis has been used as a taxation cash cow, yet a small dispensary operator still would struggle to even find a bank, let alone get a business loan or accept credit cards. While a federal solution is obviously needed, state and local governments have the scale and ability to step in as a stopgap to prevent long-term damage to smaller operators in the ecosystem.</p><p>Lastly, both the number and geographic concentration of licenses will need to be calibrated so that small businesses have opportunities to succeed while still fully serving the market. This is a significantly harder problem than it sounds, but to date nearly all states have erred on the side of under-licensing. For example, New Jersey licensed too few medical operators and <a href="https://hightimes.com/news/new-jersey-faces-medical-marijuana-shortages-program-expands/">struggled with shortages</a>. We’d much prefer to see the New York program err on the side of over-inclusion, as cannabis consumers are unlikely to be lacking for choices once the market starts moving.</p><p>The implementation of the NY cannabis market is going to be incredibly complicated and difficult by nature. We’ve been incredibly encouraged by the focus on bringing tax revenue back to the victims of the War on Drugs. The next step needs to be keeping the market open for small businesses owned and operated by the communities they serve. We know what failure would look like: the NY taxi medallion system, where pre-rideshare medallions cost over $1M to buy into the city’s legally mandated transportation oligopoly. The stakes are incredibly high, and policy leadership has the potential to start winding back the clock on 50 years of community damage.</p><p>Note: When discussing the cannabis plant (including high CBD strains), we prefer to use the scientific term (cannabis) whenever possible. Other terms often have unfortunate histories of racist use (marijuana, marihuana) or are more informal (weed, reefer, grass).</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=3c410601a4a3" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/an-end-to-war-on-drugs-is-just-the-beginning-3c410601a4a3">NYS Legalization: An End to the War on Drugs is Just the Beginning</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Announcing Vice Ventures’ Investment in Lucy]]></title>
            <link>https://medium.com/vice-ventures/announcing-vice-ventures-investment-in-lucy-52f9fb417cd9?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/52f9fb417cd9</guid>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Mon, 24 Feb 2020 22:06:30 GMT</pubDate>
            <atom:updated>2020-02-24T22:06:30.112Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*Qbb1ZkJ4H7y_7cq_T4dLZw.jpeg" /></figure><p>One of the most satisfying aspects of a role as a venture investor is the announcement of a new investment. In an industry where more than 99 our of 100 investment opportunities don’t end up as part of the fund, it’s a treat to be able to display your conviction behind an investment you feel privileged to be a part of and founders you’re honored to associate with. I’m especially proud to announce that Vice Ventures has invested in the Series A for Lucy.</p><p>As I reflect on everything that I’ve learned so far about the nicotine industry, one of the topics that lingers in my mind is the deeply challenging national environment for these products. JUUL, for instance, is a long-lasting national topic of argument, with vaping frequently referred to as a “national epidemic.” Cigarette use has continued to decrease, and smoking has become significantly less tolerated socially.</p><p>Having spent significant time with the Lucy team, my conviction in the investment continues to grow. I’ve always been a fervent believer in the crucial importance of a strong leadership team in early-stage companies, and am beyond excited to include these founders (David Renteln, John Coogan, and Samy Hamdouche) among the talented and visionary leadership teams of Vice Ventures’ investments.</p><p>The role of nicotine in society continues to evolve, and Lucy brings a fresh perspective to a space which had been remarkably stagnant before the introduction of nicotine vaporizers. Lucy’s flagship product, a nicotine gum, comes in 3 exciting flavors that have had an exciting early reception. Their customer base is comprised of people who smoke, vape, or chew and have a desire to try something new that has advantages over their previous methods of nicotine consumption.</p><p>It is no secret that many nicotine users are looking for ways to mitigate the harm associated with the various methods they use to consume it. While Lucy is not a tobacco cessation product, we see them positioned in a crucial middle ground: nicotine users who want to address the harms of consumption, consume nicotine in new and enjoyable ways, and potentially, in the future, work towards reducing consumption.</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/0*7DI2HfSwbrLkAnlD" /></figure><p>Obviously, nicotine investments come with some degree of controversy baked in. Few other consumer products have been responsible for so many human deaths. At Vice Ventures, however, we feel strongly that the field of nicotine has significant nuance within it, and that responsible companies and founders can operate in a way we feel comfortable backing. Nicotine products also carry significant regulatory risk, but we expect this to be a shorter-term risk as the supporting science becomes more clear, the FDA develops and enforces new guidance and regulations, and consumers become more educated about the products and any associated risks. We see education as a crucial aspect of the solution here, and along with the Lucy management team are very passionate about its importance.</p><p>You can check out Lucy’s ever-growing suite of nicotine products, which currently include gums and lozenges, <a href="https://lucy.co/">here</a>.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=52f9fb417cd9" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/announcing-vice-ventures-investment-in-lucy-52f9fb417cd9">Announcing Vice Ventures’ Investment in Lucy</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The End of the (Vice) World]]></title>
            <link>https://medium.com/vice-ventures/the-end-of-the-vice-world-9fc6e4186c71?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/9fc6e4186c71</guid>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[sextech]]></category>
            <category><![CDATA[cbd]]></category>
            <category><![CDATA[gambling]]></category>
            <category><![CDATA[nicotine]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Tue, 07 Jan 2020 21:05:08 GMT</pubDate>
            <atom:updated>2020-01-07T21:05:08.644Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*_tdcMImgyjKs5WA2PmfNRw.png" /></figure><p>In case you didn’t hear, we declared the vice world dead in 2019. Vapes of all kinds (THC, CBD, nicotine) killed people. PTAs across the country rallied against JUUL in their communities. Publicly traded cannabis companies made 2008 look like a bull market. A product we thought had significant political backing — CBD — came under scrutiny for its use in food. Even traditional early-stage private companies had a challenging year, with one of the largest supporters of valuations (Softbank) coming under major criticism.</p><p>The vape crisis was something that Vice Ventures interacted with directly. As investors in companies producing vaporizers (Indose) and also secular believers in the importance of vaporizers for broad cannabis consumption, the idea that vaping could kill people was absolutely terrifying. Why would someone use Indose’s vape to track exactly the quantity of consumption of an oil that could kill them at any minute?</p><p>Yet from the beginning, the vaping crisis lacked answers. Why were all of the reported fatalities from black market cartridges? In states where cannabis was legalized (and regulated) why were there fewer complaints? And, finally, we get confirmation that the<a href="https://www.cdc.gov/tobacco/basic_information/e-cigarettes/severe-lung-disease.html"> illegal use of Vitamin E acetate </a>in unregulated THC products. That sort of information really bolsters my support for national legalization and regulation of widely-used products like cannabis.</p><p>JUUL was certainly one of the villains of 2019, with parents across the country showing concern on the growing trend of teen vaping. Even the President of the United States expressed concern that “innocent children [were] coming home and they’re saying ‘Mom, I want to vape!’” Altria <a href="https://markets.businessinsider.com/news/stocks/altria-writes-down-juul-investment-by-45-billion-vaping-crackdown-2019-10-1028648264">wrote down</a> its legendary investment in JUUL and <a href="https://www.cnbc.com/2019/10/04/altria-launches-iqos-tobacco-device-in-us-and-the-timing-couldnt-be-better.html">continued developing IQOS</a>. Regardless of your personal opinion on JUUL, vaping, or the problem of growing teen use, it was a challenging year in the field of the most prominent partial-acquisitions in the vice space.</p><p>CBD, a darling of 2018, had a mixed year in 2019. After seeing tailwinds of major medicinal approvals, and the signing of the Farm Bill legalizing hemp with minimal THC content, 2019 seemed destined to be the perfect year for the CBD market. Stores started to stock a menagerie of CBD products, from creams to supplements to beverages — all offering a unique solution to a different problem. At Vice Ventures we felt that the coming years would bear some additional clarity for CBD. Obviously there were real market opportunities for it, but it was somewhat difficult to pre-judge what those would become. As a result, we only invested in companies in the space with a clear vision for how hemp/CBD was central to their brand. These companies included <a href="https://www.takearecess.com/">Recess</a>, <a href="https://plantpeople.co/">Plant People</a>, and <a href="https://www.hathcbd.com/">HATH</a>. Going forward into a market with more uncertainty, we are incredibly confident that these three companies will effectively navigate the <a href="https://www.fda.gov/news-events/public-health-focus/fda-regulation-cannabis-and-cannabis-derived-products-including-cannabidiol-cbd">regulatory challenges in front of them</a>.</p><p>All of that being said, CBD had a fantastic year in consumer education. I’d never heard so many conversations about a product before, even among people not at the forefront of wellness trends. I had conversations with an aunt with an autistic child, who used CBD to help her child calm down, I used CBD to relieve eczema, I won over sisters-in-law with samples of CBD beauty products, and I convinced my husband that cbd was not just “placebo effect medicine.”</p><p>Looking at the challenged year for valuations is simple in the listed cannabis space. The wild ride in Canadian listed cannabis shares continued — but with disastrous results. The diversified “Alternative Harvest ETF” (NYSE: MJ) was down around 7% on the year. And that, to some degree was an outperformance when Canopy Growth closed the year around $20 a share, despite Jan 18 highs over $50. While we don’t typically invest in listed companies at Vice Ventures, these companies are often sources of exits for us, and also set important targets for valuations in the field, so we hope that they’re healthy. To that point, we are confident that this public market devaluation is short-sighted and likely temporary. While retail enthusiasm for cannabis was always likely to be strong, it also helped inflate a nascent market for cannabis when it was already a major legal challenge to operate cannabis companies across states. As the market truly develops and homogenizes, we see massive potential for growth and increased profitability there. There’s no reason that nationally legalized cannabis wouldn’t be treated just like alcohol — different restrictions on packaging, sale times, sale locations, advertising, etc, but with fundamentally the same products everywhere.</p><p>Venture as a whole had a sub-par year, as Softbank drew major criticism for their investment in We, and subsequent takeover of the company (and accompanying buyout for Adam Neumann) and outsiders began to question venture valuations. These events brought up some serious questions, but I continue to feel confident that venture investing, when done properly, can create and realize incredible value for investors.</p><p>Here’s to 2020 — we survived 2019 and are optimistic for the future. 2019 was a fantastic reminder why our fund has a ten year investment horizon. Especially when dealing with politically complicated, socially unstable markets, we need to invest in businesses with a long term perspective. We’re looking to maintain diversification across vices, protecting ourselves against legal and social trends while still having upside on new social expansion. Our confidence in the field’s ability to generate returns remains strong, so we begin 2020 with enthusiasm and excitement.</p><p>Happy 2020,</p><p>Catharine Dockery</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=9fc6e4186c71" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/the-end-of-the-vice-world-9fc6e4186c71">The End of the (Vice) World</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Vice Ventures Invests in Maude]]></title>
            <link>https://medium.com/vice-ventures/vice-ventures-invests-in-maude-1072e9be8d9a?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/1072e9be8d9a</guid>
            <category><![CDATA[startup]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Thu, 14 Nov 2019 21:38:32 GMT</pubDate>
            <atom:updated>2019-11-14T21:41:34.284Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*W4MnFemYev1aKUbR-dVRBg.png" /></figure><p>When starting Vice Ventures, I was somewhat prepared for many of the misconceptions we went on to face. I expected some people to associate us solely with cannabis. I expected some people to think we had no regard for moral operators. I expected some people to see that I’m a younger female and assume I was only investing in founders with similar backgrounds. What I did not expect, however, was skepticism around the inclusion of sex companies in the fund.</p><p>I’m very excited to announce our newest investment — Maude. Maude is a sexual wellness brand that has one of the strongest brand identities that we’ve come across. They build their brand and product suite around the principles of inclusivity, simplicity, and quality. We don’t yet see the future of sexual wellness products in the “family planning” aisle at CVS, and other internet options are stigmatized or hard to trust. As society becomes more open to talking about sex and sexual wellness, we still see a relatively open market for a beautifully designed brand to emerge.</p><p>Maude is passionate about building a product that brings pleasure in an attractive form factor. As a sexual wellness brand, they have a wide product suite: vibrators, massage candles, condoms, lubricants, bath products, and wipes. The company has the highest quality standards, and we are quite excited to watch as they expand distribution and consumers get more chances to interact with the products.</p><p>The founder, Eva Goicochea, is exactly the person who we think is best equipped to lead this brand forward. She has an infectious charisma when talking about sexual wellness — within a few minutes of meeting her, this passion becomes clear. Not only that, but she’s also an incredible brand visionary and a dedicated and respected leader. We think she fits in well with the dedicated and capable founders we’ve invested in so far, and are highly confident in her leadership for the years to come.</p><p>Maude is a company for the future. They are building this vision at the leading edge of massive social change and doing so in a measured, responsible, and positive way. We are honored to be a part of their round and to partner with them for many successful years to come!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=1072e9be8d9a" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/vice-ventures-invests-in-maude-1072e9be8d9a">Vice Ventures Invests in Maude</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Vaping: Worrying for the Wrong Reasons]]></title>
            <link>https://medium.com/vice-ventures/vaping-worrying-for-the-wrong-reasons-c19d7039e2c2?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/c19d7039e2c2</guid>
            <category><![CDATA[regulation]]></category>
            <category><![CDATA[vaping]]></category>
            <category><![CDATA[thc]]></category>
            <category><![CDATA[nicotine]]></category>
            <category><![CDATA[cannabis]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Mon, 21 Oct 2019 14:45:23 GMT</pubDate>
            <atom:updated>2019-10-21T14:45:23.446Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1024/1*W9Lyt2SnJiA0xzQY7N9LUg.jpeg" /></figure><p>Vaping fears are right, but for the wrong reasons.</p><p>As a vice investor, I’m commonly asked how I alter my investment and business support philosophy to avoid social harms on par with the current vaping crises of underage use and respiratory illnesses. Almost without fail, my answer revolves around the fact that legal and destigmatized markets are easier to regulate responsibly.</p><p>Product recalls happen all the time. Companies in light markets can participate in inventory tracking and lot numbering and can protect customers when products are unintentionally subpar or dangerous. Consumers aren’t afraid to be found using these products, and so are much easier to contact and inform. Companies have a tangible incentive to preserve brand equity by making every effort to correct a mistake.</p><p>I wasn’t at all shocked to hear that illegal THC vaporizers were connected to many of the most recent illnesses in the news. Unsurprised that highly regulated markets in cannabis-legal states were uninvolved. “Dank,” one of the dangerous illegal brands in question, doesn’t have a headquarters or website to contact. They could resurface next year, choose a new brand name, and continue producing dangerous vaping liquids without any consumer knowing the difference. There’s no court to sue them in, nobody checking the quality and safety of the product, and no accountability for causing multiple deaths.</p><p>All that being said, it also needs to be a political priority to preserve regulations that provide real protection to people. The FDA has real culpability for their failure to appropriately adapt to regulate nicotine vaporizer companies. Unlike in other tobacco products, where nicotine concentrations are actively regulated, there aren’t limits on how much nicotine can be in vape liquid or on how quickly vapes can dispense that liquid. Congress banned all cigarette flavors other than methol in 2009, yet there was never many reactions to flavored vape juice until children were found with unicorn milk flavored vapes. To me, this is evidence of a regulatory body that’s not capable of properly doing their job to protect the consumer. But that can be fixed, and even when done inefficiently still eventually results in better social outcomes.</p><p>And now, due to a legalization failure (THC) combined with a regulatory failure (nicotine vapes), people have died. And rather than blame those who were supposed to regulate and work with the companies to protect consumers, we ignored their failure. In my opinion, several states have demonstrated the exact opposite mentality as they legalized cannabis, such as California which has mandated safety standards, packaging information, age verification, child-proofing, and consumer warnings. Efficient, safe, and reasonably regulated markets are the easiest way to squeeze out persistent black markets. Even in a state which taxes cannabis quite heavily, the legal market quickly overshadowed the illegal market.</p><p>Investors absolutely bear responsibility for supporting ethical founders who will have a positive effect on society. But we cannot forget that we also must focus on bringing legitimacy to vice industries by supporting safe and well-regulated markets.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=c19d7039e2c2" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/vaping-worrying-for-the-wrong-reasons-c19d7039e2c2">Vaping: Worrying for the Wrong Reasons</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[The SF E-Cigarette Ban: A Well-Intentioned Mistake]]></title>
            <link>https://medium.com/vice-ventures/the-sf-e-cigarette-ban-a-well-intentioned-mistake-d53464c72e70?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/d53464c72e70</guid>
            <category><![CDATA[vaping]]></category>
            <category><![CDATA[policy]]></category>
            <category><![CDATA[san-francisco]]></category>
            <category><![CDATA[e-cigarettes]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Mon, 01 Jul 2019 12:49:21 GMT</pubDate>
            <atom:updated>2019-07-01T12:49:21.487Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/1000/1*eOsbzgoBx0zGrulIVSSK-g.jpeg" /></figure><p>In an interview <a href="https://www.bloomberg.com/news/videos/2019-06-27/-bloomberg-technology-full-show-06-27-2019-video?in_source=video-show_14_play-episode">last week on Bloomberg TV</a>, Emily Chang asked me about my opinion on the impending San Francisco ban on the sale of e-cigarettes lacking FDA premarket approval. For those unfamiliar with this news, this action taken by San Francisco has effectively eliminated all sales of e-cigarettes (including the incredibly popular JUUL) unless they can gain FDA authorization in the next 7 months. Despite speculation that the move was intended to force the FDA approval process to move faster, it seems likely that most products will be banned when this rule comes into effect.</p><p>I’ve found few vice-related topics as divisive as e-cigarettes. As a vertical, there’s a massive divergence between the potential for social harm reduction by replacement of combustible tobacco and the dangers of underage consumption. The fact that many of these products were recently developed also leaves open some questions about their long term effects, and the involvement of big tobacco in the industry breeds distrust of consumer protections. Although I regard the e-cigarette market as largely developed (and not a promising area of early-stage venture investment), many of the questions I get from prospective investors directly relate to the national debate over JUUL and vaping.</p><p>When nicotine salts were first developed, few could predict the problems which would arise around teen vaping. Teenage nicotine use was on the lows, with young Americans trying tobacco products in record low rates. There’s no denying that underage use is a real issue and that certain elements of the products (such as flavors, product inconspicuousness, and nicotine delivery strength) exacerbated the problem. The old methods of protecting against underage consumption, which often relied on looking for smoke or smells, don’t work for vaping. The rapid spread of these products among teens is justifiably concerning to parents, but we should think twice before writing this hysteria into policy.</p><p>What concerns me most about this decision is that it feels a bit clumsy and has a real potential for unintended consequences. I mentioned on Bloomberg the fact that outright bans such as this often tend to lead to unpredictable negative effects. Banning a substance from informed adult consumers often creates more safety issues than it solves. The prohibition of alcohol was directly connected to ethanol poisonings throughout the 20s, the inclusion of cannabis as a schedule I drug helped lead to mass incarceration, and the banning of needle exchanges directly contributed to the spread of HIV. At best, prohibition has historically allowed us to cover our eyes while problems got worse.</p><p>Even on the intended purpose of reducing underage use, this plan leaves several questions irresponsibly unanswered. From a product which delivers nicotine more directly than a combustible cigarette, we now have an entire population of minors who are dependent on nicotine. If e-cigarette pods suddenly become more difficult to get than combustible cigarettes, are we not responsible for encouraging a generation of teen users into an option we know is dangerous and cancer-causing?</p><p>The current lack of FDA pre-authorization is of concern, to be sure, but when the alternatives are known to be incredibly harmful, it seems illogical to ban something simply for lacking research. The irony strikes me as well that this is happening in California, where you have cancer warnings everywhere you turn (this article is known by the State of California to cause you cancer, by the way). If San Francisco prefers more nuanced approaches in topics like sexual education, it stands to reason that they should think twice before pushing through the abstinence-only approach towards e-cigarettes.</p><p>Finally, there are also real issues around effectively banning the sale of an adults-only product to address the issue of illegal underage use. Underage individuals across the country consume alcohol, often with real impacts felt in the form of DUIs and other impaired decision making, yet we don’t call for an outright ban on the sale of alcohol. In this case, adults were absolutely using these products for harm reduction — vaping is a frequently used method to quit combustible cigarettes — a claim which can’t be made about alcohol. It feels that San Francisco has thrown up their hands at the very real problem of purchase age verification and instead sacrificed the needs of responsible and informed adults who depended on these products.</p><p>I don’t vape, or use nicotine of any kind. It’s undeniable that teen usage of all substances is a problem, and that the e-cigarette phenomenon has spread to the underage population. What’s much less clear, however, is if a black-and-white approach like an all-out ban is likely to be effective. Speaking as someone who drank while underage, I’d suspect this approach will only add to the allure of the products, raise prices teens are willing to pay and drive teens to combustible cigarettes. For that, it really isn’t worth sacrificing the needs of responsible adult users.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=d53464c72e70" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/the-sf-e-cigarette-ban-a-well-intentioned-mistake-d53464c72e70">The SF E-Cigarette Ban: A Well-Intentioned Mistake</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[It’s rare to find any silver lining in the opioid crisis.]]></title>
            <link>https://medium.com/vice-ventures/its-rare-to-find-any-silver-lining-in-the-opioid-crisis-72c6ce4500a1?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/72c6ce4500a1</guid>
            <category><![CDATA[drugs]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Thu, 13 Jun 2019 18:37:46 GMT</pubDate>
            <atom:updated>2019-06-13T18:37:46.642Z</atom:updated>
            <content:encoded><![CDATA[<h3>Decriminalizing Addiction</h3><p>It’s rare to find any silver lining in the opioid crisis. Addiction and overdoses related to opioids have been a problem for years, and this crisis has been long-developing without much acknowledgment or effort from government officials. Just a few days ago, I found this ad on the 4/5 train:</p><figure><img alt="" src="https://cdn-images-1.medium.com/max/640/0*eClO3hRPNusySsv3" /></figure><p>While the opioid crisis is tragic, this advertisement gave me hope. It’s rare to be able to observe societal change as it happens. Such an advertisement would have been impossible without a new attitude towards the use of drugs: addiction is first and foremost a medical problem and not a criminal one.</p><p>Treating addiction as a health issue is essential, and frankly requires a measure of sympathy for those struggling with the use of substances. Sadly, drug policy in the United States has often been used as a blunt tool of mass incarceration and criminalization.</p><p>The changing tones of this crisis lay bare the endemic biases in our national drug policies. I still remember my shock at the starkness of an activist’s response at a Q&amp;A session when she was asked why the opioid crisis was being treated as a health issue while cannabis enforcement had for years (and in many places continues to be) treated as a criminal issue: the color of the faces we associated with each problem is different.</p><p>Without diving too deep into the history of drug policy in the US, I find it informative to examine the current system of drug scheduling. In Schedule I we find products like cannabis, psilocybin, MDMA, and peyote — drugs which supposedly have no potential for medical purposes. Schedule II contains many opioids, including the deadly fentanyl which is to blame for many of the fatalities in the current crisis. While I don’t disagree that fentanyl could have medical uses, it’s hard to comprehend what just system would place fewer restrictions on scientific research for fentanyl than cannabis or psilocybin.</p><p>The drug scheduling system, for all its faults, is an incredibly static categorization requiring intense legislative effort to adjust. For example, hemp products (including hemp CBD), were considered part of Schedule I until the passage of the Farm Bill in 2018. It’s bizarre to think that hemp, a plant that can produce both fiber and CBD, was considered to have a higher potential for abuse and fewer applications for medicine than fentanyl. While the hemp example has since been corrected, much more work remains to be done.</p><p>We’ve been encouraged to see progress towards reorganizing the system around medical science, including an effort by Alexandria Ocasio-Cortez to eliminate language banning spending on “any activity that promotes the legalization of any drug or other substance in Schedule I.” We need to better understand these substances, and that requires a mature medical and scientific approach above fear-mongering and xenophobia.</p><p>I’m hopeful for progress on national drug policy and social opinions on drug use and addiction, driven by activists like the Drug Policy Alliance. I’ve had people ask me how I can in good conscience invest in companies in verticals like gambling, cannabis, or nicotine. Some older members of my family think I’m a drug dealer rather than an investor. These questions are generated from binary viewpoints, often the same ones which led us down a path of illogical drug scheduling, mass incarceration, and the criminalization of addiction.</p><p>At Vice Ventures, we believe strongly in the power of scientific research on substances, the importance of treating addiction as a medical condition, and in the responsibility of investors and founders to ask themselves serious questions about how products will impact consumers. Along with that comes a serious focus on harm reduction, which again should be built upon a scientific and medical approach. The other cornerstones of this approach are informed consumers, availability of addiction treatment and resources, and product quality and safety which correspond to a mature regulatory environment.</p><p>Vice Ventures enthusiastically adds our voices to the activists pushing for national reform on drug policy, incarceration, and criminalization. If you’re interested in contributing to the cause of drug policy reform in the United States, please consider donating to the Drug Policy Alliance.</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=72c6ce4500a1" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/its-rare-to-find-any-silver-lining-in-the-opioid-crisis-72c6ce4500a1">It’s rare to find any silver lining in the opioid crisis.</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Determining Informed Consumption]]></title>
            <link>https://medium.com/vice-ventures/determining-informed-consumption-b7a8d65e1269?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/b7a8d65e1269</guid>
            <category><![CDATA[mitch-mcconnell]]></category>
            <category><![CDATA[nicotine]]></category>
            <category><![CDATA[age-limit]]></category>
            <category><![CDATA[cannabis]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Mon, 22 Apr 2019 21:24:36 GMT</pubDate>
            <atom:updated>2019-04-22T21:25:11.684Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/980/1*syAmCgQ-ki1BUVbbxDqx4g.jpeg" /></figure><p>Vice is back in the news again! I had lots of questions this week about Mitch McConnell’s newest bill, which <a href="https://www.politico.com/story/2019/04/18/mcconnell-tobacco-age-21-1280950">will raise the minimum age for nicotine to 21</a>. Many people in the community have asked my thoughts here, and so I’ll try to share them succinctly below.</p><p>My initial reaction that this was terrible news for the vice community. Beyond the narrowing of the market for nicotine products, this change is emblematic of a renewed shift towards protection through legislation. How can it be positive to see new regulations inside a heavily regulated field?</p><p>From my discussions with nicotine companies, many of them had anticipated such a change. They had watched as many states, including some of the national hubs of tobacco, introduced and passed bills to raise the purchase age. A nicotine cessation company that I’ve had extensive discussions with even made the decision to create and market their product as 21+, even locations where people 18–21 could legally consume it. They made a conscious decision to prepare for changing opinions and environments. As I’ve absorbed this news, I continue to think about how prescient their choice was.</p><p>Ultimately, I see the question of age here as an issue of how well-informed consumers are. If we as a society decide that 18-year-olds lack the maturity to responsibly consume products like tobacco, it may make sense to change the legal age. I’ve always felt that prohibitions of this type had a strange effect on the market — while some consumers may be thwarted by age limits, others are enticed by the mystique of having something against the rules. This has been shown clearly with alcohol, with teenagers who want is simply because the can’t have it. Age limits always set up well for uncomfortable comparisons as well; one can enlist in the army or vote for president at 18 but still not be considered enough of an adult to make an informed decision on whether to use tobacco. In other words, I’m not opposed to increasing the age restrictions around tobacco use, but I think it misses the point. It unfairly groups and demonizes all nicotine-containing products by lumping them in with cigarettes. I would love to see further regulation that disproportionately punishes combustible tobacco companies since they’re doing the most harm to public health</p><p>It’s a strange time to be a company operating in a vice field. While nicotine continues to be demonized across the board, cannabis at least is enjoying a person of regulatory relaxation. For instance, cannabis legalization appears closer than ever to happen on a federal level. This week we saw <a href="https://www.cnbc.com/2019/04/18/canadian-weed-giant-canopy-growth-strikes-deal-to-buy-acreage.html">Canopy Growth agree to acquire Acreage Holdings for $3.4bn</a> taking effect after national legalization of cannabis is enacted. They have agreed to delay the final acquisition until legalization happens to keep their listing on stock exchanges; companies operating in federally illegal spaces can’t be publicly listed.</p><p>Overall, I don’t see the push to increase the age of nicotine consumption as especially harmful to the growth of Vice verticals. If anything, I hope it marks an encouraging shift in how US society looks to approach questions of informed consumption. I see this mentality change as an adjustment from a moralizing viewpoint towards a harm reduction focus, which is inherently positive for the broader field of vice. If we can acknowledge that humans will enjoy products that may have some negative effects on them, then we can begin to roll out regulation that favors companies who are good actors in the vice space. These actors will be transparent and will introduce products which limit those negatives and result in a better society for all</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=b7a8d65e1269" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/determining-informed-consumption-b7a8d65e1269">Determining Informed Consumption</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
        <item>
            <title><![CDATA[Building a Vice Community]]></title>
            <link>https://medium.com/vice-ventures/building-a-vice-community-fa1a559a7e4d?source=rss-c6e6662c8b6c------2</link>
            <guid isPermaLink="false">https://medium.com/p/fa1a559a7e4d</guid>
            <category><![CDATA[vice]]></category>
            <category><![CDATA[venture-capital]]></category>
            <category><![CDATA[cbd]]></category>
            <category><![CDATA[cannabis]]></category>
            <category><![CDATA[nicotine]]></category>
            <dc:creator><![CDATA[Catharine Dockery]]></dc:creator>
            <pubDate>Wed, 06 Feb 2019 05:02:10 GMT</pubDate>
            <atom:updated>2019-02-06T05:02:10.583Z</atom:updated>
            <content:encoded><![CDATA[<figure><img alt="" src="https://cdn-images-1.medium.com/max/806/1*oSygcJKokOoXUbB-pbH2Sg.png" /></figure><p><em>“Without the approval of the Advisory Board, the General Partner shall not cause the Partnership to invest for the first time in any issuer having as a material line of business (a) the research, development, manufacture and/or sale of, or of products related to, alcohol, tobacco, marijuana or pornography or (b) gambling.”</em></p><p>Vice Ventures was born to fill a gap left by the largest venture funds: a harmfully broad exclusion of investments in controversial industries. These statements, intended to reassure investors of a fund’s moral foundations, are just the start of problems faced by founders in vice fields. I’ve written, <a href="https://www.linkedin.com/pulse/introducing-vice-ventures-catharine-dockery/">Introducing Vice Ventures</a>, about why I believe painting vice industries with such a broad brush is counterproductive, but even in a fundraising environment without vice clauses, there are clear benefits to forming a community of these early-stage outcasts.</p><p>In a world where a CBD extract producer is treated the same as a cannabis vaporizer company, nicotine gum maker, online sports bookmaker, sex toy company or pornography website, I’ve found that many founders are wary of the venture community. I do not blame them one bit. Many of the founders I speak with have faced so much unfocused concern that they spend more time trying to convince me they aren’t doing something wrong than they do selling me on their growth potential as a business. I see this defensive behavior as a natural response to an investment community which has largely ignored the nuances of the many vice sub-categories, and indeed to the differences between investments in a given category.</p><p>One of the first benefits I see of a vice community is the legitimacy that comes from association. Connecting with other participants in an industry might feel counterintuitive to founders wary of competition, but in this case, the benefits of collaboration outweigh any such concerns. Vice fields are a perfect mix of underdeveloped and fast-growing. The competition will exist regardless. All that is left is to change investor sentiment. The existence of a community demonstrates the strength of vice industries to investors: VCs are far more likely to change their investment processes for high-potential industries than they are to make individual exceptions. The more success vice companies have, and the stronger their aggregation, the more forceful the push for change will be.</p><p>The benefits of a vice community extend well beyond interactions with investors. Vice companies are targeted for their industries in various ways, especially in the legal and financial arenas. They face a litany of challenges including difficulty accepting credit card payments, higher or even unknown tax rates, massive legal costs, reduced access to loans, packaging restrictions, and logistical challenges around shipping and transport. Even advertising can be a problem, with many founders struggling to make sense of state/federal regulations and social network company restrictions on content. Given the adult nature of many vice products, responsible customer acquisition is a clear opportunity for founders to share expertise. While many of these hurdles are likely to be temporary as vice industries become more accepted, vice entrepreneurs don’t have time to wait for social change to smooth the road. The vice community will be instrumental in bringing about change while also enabling new founders to navigate the murky and ever-changing environment.</p><p>Lastly, and perhaps most importantly, the formation of a vice community allows founders to share best practices around building growth in a morally acceptable way. I’ve written at length about the ways Vice Ventures evaluates the morality of investments, and I firmly believe that the best examples for founders of new vice companies are other founders. To me this is one of the largest benefits of a community: there is an incredible number of lessons to be learned from successful founders. I’ve already learned lessons from some incredible founders like Ben Witte at Recess, who has created a magical brand experience built entirely around the emotion of the product, making CBD accessible to people who never knew what it was. The founders I speak to are enthusiastic about building and benefitting from a vice community where they can learn from each other.</p><p>Vice Ventures was created with an eye to filling a funding issue felt acutely by a wave of new vice startups. Coming from that perspective, we are constantly reminded that the attitudes behind the creation of vice clauses continue to affect how startups interact with the world at large. We’re committed to building a vice community to add legitimacy to the space and help founders collaborate and succeed together. We see this as an approach where everyone wins, a way to level the playing field and enable truly great companies to shine. If you’re a founder in a vice industry, an investor looking to hear more about what we’re looking to build, or just interested in our mission, we’d love to hear from you!</p><img src="https://medium.com/_/stat?event=post.clientViewed&referrerSource=full_rss&postId=fa1a559a7e4d" width="1" height="1" alt=""><hr><p><a href="https://medium.com/vice-ventures/building-a-vice-community-fa1a559a7e4d">Building a Vice Community</a> was originally published in <a href="https://medium.com/vice-ventures">Vice Ventures</a> on Medium, where people are continuing the conversation by highlighting and responding to this story.</p>]]></content:encoded>
        </item>
    </channel>
</rss>